Anticoagulants nsaids or aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Blood Platelets Gastric Mucosa Endothelium, Vascular

Organisms6

Sea Cucumbers Seaweed Phaeophyta Ancylostoma Rabbits Strongylida

Diseases54

Hemorrhage Thrombosis Thromboembolism Antiphospholipid Syndrome Gastrointestinal Diseases Thrombophlebitis Venous Thrombosis Gastrointestinal Hemorrhage Thrombophilia Venous Thromboembolism Blood Coagulation Disorders Pulmonary Embolism Atrial Fibrillation Stomach Ulcer Stroke Activated Protein C Resistance Peptic Ulcer Recurrence Peptic Ulcer Hemorrhage Drug Hypersensitivity Protein C Deficiency Asthma, Aspirin-Induced Postoperative Hemorrhage Protein S Deficiency Hematoma Antithrombin III Deficiency Osteoarthritis Myocardial Infarction Embolism Lupus Erythematosus, Systemic Cerebral Hemorrhage Cerebrovascular Disorders Hypoprothrombinemias Cardiovascular Diseases Hemorrhagic Disorders Arthritis Intracranial Embolism and Thrombosis Abortion, Habitual Coagulation Protein Disorders Hematoma, Subdural Ischemic Attack, Transient Pregnancy Complications, Hematologic Disseminated Intravascular Coagulation Colorectal Neoplasms Duodenal Ulcer Coronary Thrombosis Pain Stomach Diseases Pregnancy Complications, Cardiovascular Intracranial Hemorrhages Brain Ischemia Acute Disease Thrombocytopenia Postoperative Complications

Chemicals and Drugs129

Aspirin Anticoagulants Anti-Inflammatory Agents, Non-Steroidal Lupus Coagulation Inhibitor Warfarin Platelet Aggregation Inhibitors Protein C Cyclooxygenase Inhibitors Heparin Cyclooxygenase 2 Inhibitors Ibuprofen Rodenticides Acenocoumarol Factor Xa Phenindione Antithrombins 4-Hydroxycoumarins Naproxen Diclofenac Heparin, Low-Molecular-Weight Protein S Blood Coagulation Factors beta-Alanine Thrombomodulin Prothrombin Thrombin Prostaglandin-Endoperoxide Synthases Vitamin K Fibrinolytic Agents Cyclooxygenase 1 Antibodies, Antiphospholipid Cyclooxygenase 2 Acetaminophen Pyrazoles Ticlopidine Phenprocoumon Antithrombin III Salicylates Antibodies, Anticardiolipin Indomethacin Thromboxane B2 Ketoprofen Sulfonamides Sulindac Piroxicam Hirudins Sulfones Thromboplastin Heparin Antagonists Etodolac Factor X Lactones Factor V Analgesics, Non-Narcotic Thiophenes Enoxaparin Thiazines Coagulants beta 2-Glycoprotein I Dicumarol Pipecolic Acids Factor Va Nitrobenzenes Sodium Salicylate Pyridones Benzimidazoles Dermatan Sulfate Dalteparin Vitamin K Epoxide Reductases Dinoprostone Coumarins Heparin Cofactor II Isoenzymes Prostaglandins Cardiolipins Tablets, Enteric-Coated Fibrin Polysaccharides Arthropod Proteins Dipyridamole Antithrombin Proteins Factor VIIa Fibrin Fibrinogen Degradation Products Anti-Ulcer Agents Anti-Inflammatory Agents Factor VIIIa Citric Acid Factor VII Ketorolac Anticarcinogenic Agents Misoprostol Fibrinogen Membrane Proteins Morpholines Heparitin Sulfate Proton Pump Inhibitors Thromboxanes Heparinoids Citrates Epoprostenol Nadroparin Thromboxane A2 Phospholipids Hemostatics Recombinant Proteins Analgesics Ancrod Salicylic Acid Azetidines Prostaglandin Antagonists Chromogenic Compounds Glycoproteins Protein C Inhibitor Serine Proteinase Inhibitors Edetic Acid Benzylamines Lipoxins Salivary Proteins and Peptides Arachidonic Acid Factor IX Heparin Lyase Drug Combinations Factor IXa Sulfinpyrazone Receptors, Thrombin Factor VIII Annexin A5 Annexins Platelet Glycoprotein GPIIb-IIIa Complex

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Prothrombin Time Partial Thromboplastin Time Blood Coagulation Tests International Normalized Ratio Thrombin Time Administration, Oral Risk Factors Drug Therapy, Combination Treatment Outcome Platelet Function Tests Prospective Studies Bleeding Time Randomized Controlled Trials as Topic Drug Monitoring Double-Blind Method Risk Assessment Follow-Up Studies Drug Administration Schedule Retrospective Studies Incidence Case-Control Studies Cohort Studies Risk Clinical Trials as Topic Whole Blood Coagulation Time Platelet Count Drug Prescriptions Chemoprevention Heart Valve Prosthesis Thrombelastography Perioperative Care Blood Preservation Hirudin Therapy Blood Specimen Collection Odds Ratio Thrombolytic Therapy Pharmacovigilance Cross-Over Studies Chromatography, High Pressure Liquid

Psychiatry and Psychology1

Phenomena and Processes22

Blood Coagulation Prothrombin Time Partial Thromboplastin Time Thrombin Time Platelet Aggregation Dose-Response Relationship, Drug Hemostasis Drug Interactions Time Factors Bleeding Time Platelet Activation Risk Fibrinolysis Whole Blood Coagulation Time Drug Resistance Platelet Count Odds Ratio Pain Pregnancy Kinetics Structure-Activity Relationship Drug Synergism

Anthropology, Education, Sociology and Social Phenomena1

Safety-Based Drug Withdrawals

Information Science2

Incidence Pharmacovigilance

Health Care25

Risk Factors Treatment Outcome Prospective Studies Rodent Control Randomized Controlled Trials as Topic Double-Blind Method Risk Assessment Follow-Up Studies Retrospective Studies Safety-Based Drug Withdrawals Drug Utilization Incidence Case-Control Studies Cohort Studies Risk Clinical Trials as Topic Drug Prescriptions Perioperative Care Odds Ratio Practice Guidelines as Topic Drug Costs Pharmacovigilance Physician's Practice Patterns Cross-Over Studies Secondary Prevention

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Aspirin Anticoagulants Anti-Inflammatory Agents, Non-Steroidal Lupus Coagulation Inhibitor Warfarin Blood Coagulation Platelet Aggregation Inhibitors Prothrombin Time Protein C Cyclooxygenase Inhibitors Heparin Cyclooxygenase 2 Inhibitors Partial Thromboplastin Time Ibuprofen Rodenticides Acenocoumarol Factor Xa Phenindione Antithrombins Hemorrhage Blood Coagulation Tests 4-Hydroxycoumarins Thrombosis Thromboembolism International Normalized Ratio Thrombin Time Naproxen Diclofenac Heparin, Low-Molecular-Weight Protein S Blood Coagulation Factors beta-Alanine Thrombomodulin Prothrombin Thrombin Antiphospholipid Syndrome Prostaglandin-Endoperoxide Synthases Administration, Oral Vitamin K Fibrinolytic Agents Gastrointestinal Diseases Cyclooxygenase 1 Antibodies, Antiphospholipid Thrombophlebitis Cyclooxygenase 2 Venous Thrombosis Acetaminophen Pyrazoles Gastrointestinal Hemorrhage Ticlopidine Phenprocoumon Antithrombin III Salicylates Antibodies, Anticardiolipin Platelet Aggregation Risk Factors Thrombophilia Indomethacin Drug Therapy, Combination Venous Thromboembolism Blood Coagulation Disorders Thromboxane B2 Pulmonary Embolism Ketoprofen Sulfonamides Blood Platelets Sulindac Dose-Response Relationship, Drug Atrial Fibrillation Treatment Outcome Piroxicam Hirudins Sulfones Thromboplastin Heparin Antagonists Stomach Ulcer Hemostasis Etodolac Factor X Drug Interactions Platelet Function Tests Lactones Factor V Analgesics, Non-Narcotic Thiophenes Time Factors Enoxaparin Thiazines Coagulants beta 2-Glycoprotein I Stroke Dicumarol Prospective Studies Pipecolic Acids Activated Protein C Resistance Factor Va Bleeding Time Rodent Control Nitrobenzenes Peptic Ulcer

No FAQ available that match "anticoagulants nsaids or aspirin"